Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998-2007.

[1]  J. R. Landis,et al.  An index of risk for obstructive airways disease. , 2015, The American review of respiratory disease.

[2]  M. Lebowitz,et al.  The relationship of childhood respiratory illness to adult obstructive airway disease. , 2015, The American review of respiratory disease.

[3]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[4]  N. Anthonisen,et al.  Chronic obstructive pulmonary disease (COPD). , 1998, American journal of respiratory and critical care medicine.

[5]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997, JAMA.

[6]  Alison E. Ries.  Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. , 1997, Chest.

[7]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[8]  K. Fagerström,et al.  The tobacco epidemic , 1997 .

[9]  R. Zuwallack,et al.  Body composition and health-related quality of life in patients with obstructive airways disease. , 1997, The European respiratory journal.

[10]  R. Badgett,et al.  Is screening for chronic obstructive pulmonary disease justified? , 1997, Preventive medicine.

[11]  P. Andersen,et al.  Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. , 1997, The European respiratory journal.

[12]  W. McNicholas,et al.  Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. , 1997, The American journal of medicine.

[13]  H. Hamm,et al.  The role of pulmonary surfactant in obstructive airways disease. , 1997, The European respiratory journal.

[14]  M. Decramer,et al.  Muscle weakness is related to utilization of health care resources in COPD patients. , 1997, The European respiratory journal.

[15]  C. Clark.  Is pulmonary rehabilitation effective for patients with COPD? , 1996, The Lancet.

[16]  Gordon H Guyatt,et al.  Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease , 1996, The Lancet.

[17]  C. P. Schayck,et al.  Do patients with COPD benefit from treatment with inhaled corticosteroids? , 1996, The European respiratory journal.

[18]  V M Hawthorne,et al.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.

[19]  E. Vartiainen,et al.  Symptoms of chronic bronchitis and the risk of coronary disease , 1996, The Lancet.

[20]  S. Kivelä,et al.  Hospital admissions for chronic obstructive pulmonary disease in the population aged 55 years or over in Finland during 1972-1992. , 1996, Public health.

[21]  N. Ambrosino.  Noninvasive mechanical ventilation in acute respiratory failure. , 1996, The European respiratory journal.

[22]  Kansaneläkelaitos Kela,et al.  Kansaneläkelaitoksen kuntoutustilastot 1995 , 1996 .

[23]  S. Kivelä,et al.  Age distribution of patients treated in hospital for chronic obstructive pulmonary disease. , 1996, Age and ageing.

[24]  L. Kinlen.  Mortality from smoking in developed countries 1950-2000 , 1996, British Journal of Cancer.

[25]  J. Henningfield.  Nicotine medications for smoking cessation. , 1995, The New England journal of medicine.

[26]  L. Fabbri,et al.  Effect of smoking cessation on airway inflammation in chronic bronchitis. , 1995, American journal of respiratory and critical care medicine.

[27]  Adams Ja.  Smoking cessation counseling in adults and children: the clinician's role. , 1995 .

[28]  B. Celli.  Pulmonary rehabilitation in patients with COPD. , 1995, American journal of respiratory and critical care medicine.

[29]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[30]  R. Wilson.  Outcome predictors in bronchitis. , 1995, Chest.

[31]  P. Ball.  Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations , 1995, Chest.

[32]  N. Gross.  Airway inflammation in COPD. Reality or myth? , 1995, Chest.

[33]  S. Ahlstedt,et al.  Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. , 1995, Thorax.

[34]  C. Cooper.  Determining the role of exercise in patients with chronic pulmonary disease. , 1995, Medicine and science in sports and exercise.

[35]  M. Sridhar.  Nutrition and lung health , 1995, BMJ.

[36]  C. Donner,et al.  Airways inflammation in subjects with chronic bronchitis who have never smoked. , 1994, Thorax.

[37]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[38]  A. Woolcock,et al.  Studies of airway inflammation in asthma and chronic airflow limitation. Do they help to explain causes? , 1994, American journal of respiratory and critical care medicine.

[39]  P. Jeffery.  Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[40]  J. Hasday,et al.  Dysregulation of airway cytokine expression in chronic obstructive pulmonary disease and asthma. , 1994, American journal of respiratory and critical care medicine.

[41]  R. Peto,et al.  Smoking and death: the past 40 years and the next 40 , 1994, BMJ.

[42]  A. Ries.  The importance of exercise in pulmonary rehabilitation. , 1994, Clinics in chest medicine.

[43]  H. Kromhout,et al.  Occupational exposures estimated by a population specific job exposure matrix and 25 year incidence rate of chronic nonspecific lung disease (CNSLD): the Zutphen Study. , 1994, The European respiratory journal.

[44]  P. Burge.  Occupation and chronic obstructive pulmonary disease (COPD) , 1994, The European respiratory journal.

[45]  D. Barker,et al.  Early lung growth and chronic airflow obstruction. , 1994, Thorax.

[46]  P. Helms.  Lung growth: implications for the development of disease. , 1994, Thorax.

[47]  H. Folgering,et al.  Exercise Limitations in Patients with Pulmonary Diseases , 1994, International journal of sports medicine.

[48]  D. Postma,et al.  Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. , 1994, The European respiratory journal.

[49]  P. Venge,et al.  Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. , 1993, The American review of respiratory disease.

[50]  J. Bousquet,et al.  Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. , 1993, The Journal of allergy and clinical immunology.

[51]  Rodrigues Jc,et al.  Pulmonary rehabilitation in the elderly patient. , 1993 .

[52]  R. Aalbers,et al.  Inflammation and bronchial hyperresponsiveness in allergic asthma and chronic obstructive pulmonary disease. , 1993, Respiratory medicine.

[53]  E. Feskens,et al.  Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study. , 1993, American journal of epidemiology.

[54]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[55]  J. Samet,et al.  Particulate air pollution and health. New evidence on an old problem. , 1993, The American review of respiratory disease.

[56]  S. Rennard,et al.  Assessment of airways inflammation in chronic bronchitis. , 1993, The European respiratory journal.

[57]  D. Menzel.  Antioxidants in Lung Disease , 1993, Toxicology and industrial health.

[58]  A. Miller,et al.  Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.

[59]  T. Murphy,et al.  Bacterial infection in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[60]  Alan D. Lopez,et al.  Mortality from tobacco in developed countries: indirect estimation from national vital statistics , 1992, The Lancet.

[61]  T. Glynn,et al.  The clinician's role in promoting smoking cessation among clinic patients. , 1992, The Medical clinics of North America.

[62]  M. Manley,et al.  The clinician's role in preventing smoking initiation. , 1992, The Medical clinics of North America.

[63]  C. Sherman,et al.  The health consequences of cigarette smoking. Pulmonary diseases. , 1992, The Medical clinics of North America.

[64]  J. L. Schwartz,et al.  Methods for smoking cessation. , 1992, Clinics in chest medicine.

[65]  A. Gulsvik,et al.  Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. , 1991, Thorax.

[66]  K. Godfrey,et al.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. , 1991, BMJ.

[67]  L. Laitinen,et al.  Cellular infiltrates in asthma and in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[68]  L. Nyström,et al.  Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. , 1991, The European respiratory journal.

[69]  R. Rogers,et al.  Nutritional assessment and support in chronic obstructive pulmonary disease. , 1990, Clinics in chest medicine.

[70]  M. Lebowitz,et al.  Epidemiology of chronic obstructive pulmonary disease. , 1990, Clinics in chest medicine.

[71]  Thurlbeck Wm.  Pathophysiology of chronic obstructive pulmonary disease. , 1990 .

[72]  I. Ziment.  Pharmacologic therapy of obstructive airway disease. , 1990, Clinics in chest medicine.

[73]  B. Burrows.  Airways obstructive diseases: pathogenetic mechanisms and natural histories of the disorders. , 1990, The Medical clinics of North America.

[74]  A. Lahdensuo,et al.  Effects of supervised exercise training on physical work capacity in a group of patients with severe chronic obstructive pulmonary disease , 1990 .

[75]  A. Woolcock,et al.  Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia. , 1990, Thorax.

[76]  M. Feinleib,et al.  Trends in COPD morbidity and mortality in the United States. , 1989, The American review of respiratory disease.

[77]  M. Becklake.  Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[78]  T. Thom.  International comparisons in COPD mortality. , 1989, The American review of respiratory disease.

[79]  J. Manfreda,et al.  Morbidity and mortality from chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[80]  G. Snider.  Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. , 1989, The American review of respiratory disease.

[81]  M. Lebowitz.  The trends in airway obstructive disease morbidity in the Tucson Epidemiological Study. , 1989, The American review of respiratory disease.

[82]  T. Novotny,et al.  The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[83]  M. Higgins,et al.  Trends in COPD morbidity and mortality in Tecumseh, Michigan. , 1989, The American review of respiratory disease.

[84]  A. Woolcock.  Epidemiology of chronic airways disease. , 1989, Chest.

[85]  J. Hogg,et al.  Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function. , 1987, Thorax.

[86]  M. Wysocki,et al.  Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease. , 1986, The American review of respiratory disease.

[87]  C. Harris.  Tobacco smoke and lung disease: who is susceptible? , 1986, Annals of internal medicine.

[88]  W M Thurlbeck,et al.  The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth. , 1982, Thorax.

[89]  W. F. Miller,et al.  Pulmonary function assessment for determination of pulmonary impairment and disability evaluation. , 1981, Clinics in chest medicine.

[90]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[91]  U. Bucher,et al.  Development of the Intrasegmental Bronchial Tree: the Pattern of Branching and Development of Cartilage at Various Stages of Intra-uterine Life * , 1961, Thorax.

[92]  J. Wright,et al.  Diseases of the small airways. , 2001, Lung.

[93]  Leena Von Herzen.  Chlamydia pneumoniae infection in chronic obstructive pulmonary disease - diagnostic, epidemiological and immunological aspects , 1996 .

[94]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[95]  P. Jeffery.  Histological features of the airways in asthma and COPD. , 1992, Respiration; international review of thoracic diseases.

[96]  L. Trevisani,et al.  Structural characterization of the bronchial epithelium of subjects with chronic bronchitis and in asymptomatic smokers. , 1992, Respiration; international review of thoracic diseases.

[97]  Pekka Puska,et al.  Suomalaisen aikuisväestön terveyskäyttäytyminen, kevät 1991 , 1991 .

[98]  E. Huhti,et al.  A 10-year follow-up study of respiratory symptoms and ventilatory function in a middle-aged rural population. , 1980 .

[99]  E. Huhti.  Prevalence of respiratory symptoms, chronic bronchitis and pulmonary emphysema in a Finnish rural population. Field survey of age group 40-64 in the Harjavalta area. , 1965, Acta tuberculosea et pneumologica Scandinavica. Supplementum.